Menu Back toSession-2-Non-Interventional-Studies-Study-Design-Considerations-and-Current-Applications

Real World Evidence Conference

This conference has reached maximum capacity.


Session 2: Non-Interventional Studies: Study Design Considerations and Current Applications

Session Chair(s)

Brian D. Bradbury, PhD, MA

Brian D. Bradbury, PhD, MA

  • Executive Director & Head, Data and Analytics, Center for Observational Research
  • Amgen, Inc., United States
This session is designed to provide you with a general understanding of key design and analytic principles for non-interventional studies evaluating treatment effects. The session will present examples of high-quality non-interventional studies designed to evaluate the effectiveness and safety of therapeutic interventions and discuss key sources of bias and approaches to handling them.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify key design and analytic considerations for conducting non-interventional studies to evaluate drug effectiveness and safety
  • Identify examples of high-quality non-interventional studies
  • Identify key sources of bias in non-interventional studies and approaches to addressing them

Speaker(s)

Sebastian  Schneeweiss, DrSc, MD, MS, FISPE

Real World Data Analyses: Causal Study Designs

Sebastian Schneeweiss, DrSc, MD, MS, FISPE

  • Professor of Medicine and Epidemiology
  • Harvard Medical School and Brigham & Women's Hospital, United States
David T Gilbertson, PhD

Non-Interventional Studies: Study Design Considerations and Current Applications

David T Gilbertson, PhD

  • Co-Director
  • Chronic Disease Research Group, United States
Alan  Brookhart

Non-Interventional Studies: Study Design Considerations and Current Applications

Alan Brookhart

  • Professor, Department of Epidemiology, Gillings School of Global Public Health
  • University of North Carolina, Chapel Hill, United States

Contact us

Customer Service

1.888.257.6457